H.R. 235 · 118th Congress (2023–2025)
Triple-Negative Breast Cancer Research and Education Act of 2023
This bill requires research and education activities related to triple-negative breast cancer. The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so they do not respond to hormonal therapy medicines or medicines that target the HER2 protein receptors.
Specifically, the National Institutes of Health must conduct and support research into the disease.
Additionally, the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop information about triple-negative breast cancer, including information regarding the elevated risk for minority women, for the public and for health care providers.
Show official title
To provide for research and education with respect to triple-negative breast cancer, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 235’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Sheila Jackson Lee (D-TX-18)
- Cosponsors
12 cosponsors
0 original · 12 later
1 R · 11 D
- Rep. Gwen Moore (D-WI-4)· Later · Oct 10, 2023
- Rep. Don Bacon (R-NE-2)· Later · Oct 11, 2023
- Rep. Joseph D. Morelle (D-NY-25)· Later · Oct 11, 2023
- Rep. Paul Tonko (D-NY-20)· Later · Oct 16, 2023
- Rep. Nikema Williams (D-GA-5)· Later · Oct 18, 2023
- Rep. Glenn Ivey (D-MD-4)· Later · Oct 25, 2023
- Rep. Dwight Evans (D-PA-3)· Later · Oct 26, 2023
- Rep. Troy A. Carter (D-LA-2)· Later · Nov 6, 2023
- Rep. Jonathan L. Jackson (D-IL-1)· Later · Mar 21, 2024
- Rep. Jared Moskowitz (D-FL-23)· Later · Mar 26, 2024
- Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Jul 15, 2024
- Rep. Terri A. Sewell (D-AL-7)· Later · Jul 15, 2024
- Policy area
- Health
- Subjects
- Cancer
- Government information and archives
- Health information and medical records
- Health programs administration and funding
- Health promotion and preventive care
- Medical education
- Medical research
- Minority health
2 more
- Research administration and funding
- Women's health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Jan 10, 2023 – Jan 20, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Triple-Negative Breast Cancer Research and Education Act of 2023
Display title, Short title · Introduced in House
To provide for research and education with respect to triple-negative breast cancer, and for other purposes.
Official title · Introduced in House